Introduction
============

Alzheimer's disease (AD) is the most common type of dementia. According to the amyloid hypothesis, amyloid-beta (Aβ) is the primary factor to initiate a pathogenic cascade of AD in the brain (see review in [@ref-15]). Aβ is generated from proteolysis of its precursor, amyloid precursor protein (APP). The oligomeric assemblies of Aβ that form amyloid plaques in extracellular space of neuron cell cause synaptic loss between neurons. Endocytosis is one of the biological pathways affecting APP trafficking and many endocytosis genes, including *BIN1*, *CD2AP*, *PICALM*, *EPHA1* and *SORL1* were identified as AD-associated in genome wide association study (GWAS) and other genetic studies (see review in [@ref-18]).

From a study by [@ref-46], 40 types of Aβ modifiers were identified through a yeast genome-wide overexpression study, which demonstrated a genetic link between Aβ and endocytosis pathway in the pathogenesis of AD. There are two types of Aβ modifiers, namely Aβ suppressors, which decrease the toxicity of soluble Aβ oligomers and Aβ enhancers, which increase the toxicity. Among the identified Aβ modifiers, three of the Aβ suppressors are involved in endocytosis, namely *YAP1802*, *INP52* and *SLA1*, and they have human orthologues, *PICALM*, *SYNJ1* and *SH3KBP1*, respectively. Orthologous genes typically have similar biological function. Therefore, these three human orthologue genes may also play a role in modifying the toxicity of Aβ oligomers in human. Besides that, these human orthologues also play a role in clathrin-mediated endocytosis (CME), which is the major route for synaptic vesicle recycling (see review in [@ref-30]). In addition, CME and its regulators have also been linked to the trafficking of Aβ ([@ref-14]). Therefore, it is of great interest to study the potential biological roles of *PICALM*, *SYNJ1* and *SH3KBP1* genes in the pathogenesis of AD.

PICALM (Phosphatidylinositol binding clathrin assembly protein) is mostly expressed in the brain capillary endothelium and neuron cells, and it is involved in cellular trafficking and the formation of clathrin-coated pit during CME ([@ref-45]). *PICALM* gene is one of the validated AD risk genes first identified in a GWAS ([@ref-20]). The increased level of PICALM protein promotes the internalization of APP while its reduction causes the translocation of APP on the cell surface ([@ref-50]). Besides that, PICALM helps in Aβ clearance by increasing Aβ translocation across the blood--brain barrier ([@ref-55]). Several *PICALM* variants, including [rs3851179](http://www.ncbi.nlm.nih.gov/snp/?term=rs3851179) and [rs592297](http://www.ncbi.nlm.nih.gov/snp/?term=rs592297), were identified to be associated with AD ([@ref-20]).

SYNJ1 (Synaptojanin 1) is the major synaptic polyphosphoinositide phosphatase, which regulates the uncoating and remobilization of synaptic vesicles during CME at the axon terminus ([@ref-12]). SYNJ1 interacts with one of the AD risk genes, BIN1 (Bridging integrator 1) ([@ref-37]). ApoE4-induced upregulation of SYNJ1 leads to the phospholipid homeostatic dysregulation in the brain, which is associated with the cognitive deficits in AD ([@ref-57]). Conversely, downregulation of SYNJ1 not only restores the phospholipid homeostasis, but also reduces the level of phosphorylated tau protein *in vitro* ([@ref-8]). On the other hand, variant in *SYNJ1* gene was found to be associated with the heritable form of Parkinson's disease (PD) ([@ref-24]).

SH3KBP1 (SH3-Domain Kinase Binding Protein 1), also known as CIN85, is an adaptor protein with multiple cellular functions through binding to different protein partners. *SH3KBP1* is a homologous gene to one of the validated AD risk genes, *CD2AP* (see review in [@ref-39]). These two homologous genes were reported to have high sequence and structural similarities, and they were identified as interacting partners ([@ref-32]). A transgenic *Drosophila* study also showed the reduction of *cindr* gene expression, a fly orthologue of *SH3KBP1*, increased tau neurotoxicity ([@ref-42]).

Single nucleotide polymorphisms (SNPs) play important roles in many complex human diseases, including auto-immune diseases, diabetes and schizophrenia (see review in [@ref-47]). SNPs that fall on either coding or non-coding regions of a genome can exert their biological effects and could cause diseases. There are two types of SNPs in the coding regions, namely synonymous SNPs (sSNPs) and non-synonymous SNPs (nsSNPs). For sSNPs, they do not change the amino acid sequence of a translated protein. However, they can exert their biological consequences through changes in alternative splicing, mRNA stability or translation rate (see review in [@ref-41]). While for nsSNPs, these variants cause amino acids substitution and may have direct structural and functional impacts to the proteins. Non-coding regions SNPs may affect transcription factor binding, gene splicing, RNA degradation and other biological processes.

Previous studies have demonstrated the important roles of genetic variants in the development of AD. However, there are limited studies about the functional variants in these AD-associated endocytosis genes, especially *SYNJ1* and *SH3KBP1* genes. In this study, the effect of UTR variants, splice site variants, sSNPs and nsSNPs in *PICALM*, *SYNJ1* and *SH3KBP1* genes, was predicted and analyzed using computational methods. The variants with high probability of affecting the protein structure and function are identified in the present study.

Material and Methods
====================

Dataset retrieval
-----------------

The information of the genes of interest was retrieved from the Ensembl genome database (release 87) (<http://www.ensembl.org/index.html>) in March 2017 for computational analysis. Ensembl comprises the variant data from multiple sources, such as dbSNP, COSMIC and DVGa. The positions of the variants were mapped on the human reference genome GRCh38, which is also equivalent to the UCSC (University of California, Santa Cruz) hg38.

Analysis of UTRs variants
-------------------------

Both 3′and 5′ UTR sequences of the genes of interest were collected from the curated database, UTRdb (<http://utrdb.ba.itb.cnr.it/>). These sequences with different variants were submitted to the UTRScan, which is a pattern matcher to search for UTR motifs collected in UTRSite ([@ref-19]). UTRSite is a collection of functional sequence patterns located in 3′ and 5′ UTR sequences, such as upstream open reading frame (uORF), internal ribosome entry site (IRES), and polyadenylation signal (PAS). If different functional patterns are found between wild type and mutant UTR sequences, the variant is predicted to be functionally significant.

Analysis of splice site variants
--------------------------------

The impact of splice site variants was predicted by using MaxEntScan integrated in Ensembl Variant Effect Predictor (VEP) (<http://www.ensembl.org/Tools/VEP>), which implements the Maximum Entropy Distribution approach. The input for the VEP requires only variant identifier (variant ID). For each variant, a consensus score with value in the range of −20 to +20 is calculated by MaxEntScan. Then, the score difference (in percentage) between wild type and mutant is calculated manually. The consensus score threshold of 3 and score difference threshold of 30% were applied to predict the splice site variants from both positive and negative controls ([@ref-13]). [Table S1](#supp-5){ref-type="supplementary-material"} shows the possible consequences of splice site variants predicted by MaxEntScan.

Analysis of sSNPs
-----------------

PredictSNP2 (<http://loschmidt.chemi.muni.cz/predictsnp2/>) is a web server that predicts the effect of nucleotide substitution in any region of the genome. The server integrates five prediction tools---CADD, DANN, FATHMM, FunSeq2 and GWAVA ([@ref-5]). The consensus score generated by PredictSNP2 ranges from −1 to +1, in which the variant is considered neutral if the consensus score falls between −1 and 0, and is deleterious if the consensus score falls between 0 and +1.

Analysis of nsSNPs
------------------

Five prediction software packages that implement different prediction methodologies, namely SIFT ([@ref-33]), PolyPhen-2 ([@ref-1]), Mutation Assessor ([@ref-38]), I-Mutant2.0 ([@ref-10]) and SNPs&GO ([@ref-9]), were used to predict the deleteriousness of all the nsSNPs. The nsSNPs that passed all the default cutoff points were considered to be deleterious nsSNPs. Then, the degree of evolutionary conservation of the deleterious nsSNPs was estimated using the ConSurf server ([@ref-2]), and the mutant protein structures were modelled and refined by SPARKS-X ([@ref-52]) and ModRefiner ([@ref-51]).

SIFT (Sorting Intolerant From Tolerant, version 5.2.2) from <http://sift.jcvi.org/> is a sequence conservation-based package that predicts the functional impact of amino acid substitution based on sequence homology and physiochemical diversity ([@ref-33]). The cutoff point was set at 0.05, so variants with a SIFT score lower than 0.05 were considered deleterious.

PolyPhen-2 (Polymorphism phenotype 2, version 2.2.2) from <http://genetics.bwh.harvard.edu/pph2/>, is a sequence- and structure-based prediction package. It predicts the impact of nsSNPs based on sequential and structural features collected from multiple databases and tools, such as UniProtKB, BLAST, Pfam and DSSP ([@ref-1]). The cutoff point was set at 0.9, so variants with PolyPhen-2 score (known as PSIC score) higher than 0.9 were categorized as probably damaging.

Mutation Assessor (release 3) from <http://mutationassessor.org/r3/> performs the sequence conservation-based prediction by assessing the entropy differences of an alignment position. It uses the sequence homology information of both protein families and subfamilies to assess the level of conservation of each residue ([@ref-38]). The functional impact of the variants was categorized into "neutral", "low", "medium" or "high" impact categories. In this study, the cutoff level for the deleterious variant was set at "medium" or "high" impact.

I-Mutant2.0 (<http://folding.biofold.org/i-mutant/i-mutant2.0.html>) is a structure analysis-based prediction software that analyzes the protein stability change for a single point variant ([@ref-10]). I-Mutant2.0 works by calculating the change in Gibbs free energy between the wild type and mutant protein structures. Variants with energy change value (DDG) less than −1 or greater than 1 indicate that these variants are destabilizing or stabilizing the protein, respectively.

SNPs&GO (Single Nucleotide Polymorphism Database & Gene Ontology), at <http://snps.biofold.org/snps-and-go/snps-and-go.html>, combines both sequence and structure information to perform prediction. Information from Gene Ontology terms is also taken into consideration in predicting the functional impact of the variants ([@ref-9]). The cutoff point was set at 0.5, so variants with probability greater than 0.5 were predicted as disease-related.

ConSurf (<http://consurf.tau.ac.il/2016/>) is a widely used evolutionary conservation analysis tools based on amino acid positions among the homologous protein sequences ([@ref-2]). In ConSurf, the conservation score of each protein residue indicates the level of conservation, with score "1" indicating the residue is highly variable and score "9" indicating the residue is highly conserved. Residues are also predicted to be buried (b), exposed (e), highly conserved and exposed (functional, f), or highly conserved and buried (structural, s).

SPARKS-X fold recognition server (<http://sparks-lab.org/yueyang/server/SPARKS-X/index.php>) is a template-based protein structure modelling tool ([@ref-52]). The modelled protein structures were refined by using ModRefiner, which is a structure refinement server that improves the structure quality, in terms of side-chain positioning and backbone topology ([@ref-51]). The structural impacts of the nsSNPs can be predicted by studying the total free energy changes between the wild type and mutant protein structures, as well as the root mean square deviation (RMSD) of the mutant structures from the native protein structure.

Results
=======

Dataset retrieval from Ensembl
------------------------------

The SNP datasets of *PICALM*, *SYNJ1* and *SH3KBP1* genes were retrieved from the Ensembl genome database. It contained a total of 1741 SNPs, including 395 UTRs (22%) variants, 188 (11%) splice site variants, 399 (23%) sSNPs and 759 (43%) nsSNPs. Out of a total of 759 nsSNPs in the genes of interest, 106 were classified as "deleterious" in SIFT and "probably damaging" in PolyPhen-2, according to the results in the Ensembl genome database. [Figure S1](#supp-1){ref-type="supplementary-material"} shows the total number of variants used in this study.

Prediction analysis of UTRs variants
------------------------------------

The information of the retrieved UTR sequences and the total number of variants on the corresponding region are shown in [Table S2](#supp-6){ref-type="supplementary-material"}. There were no 5′ UTR variants in *SYNJ1* gene in the Ensembl genome database.

In the wild type UTR sequences of *PICALM* gene, a total of 11 motifs were identified from the UTRScan. Out of a total of 35 UTR variants in *PICALM* gene, only one 3′  UTR variant, [rs796143140](http://www.ncbi.nlm.nih.gov/snp/?term=rs796143140), caused an additional motif, namely K-box at position 212--219 of 3′ UTR sequence. K-box is one of the 3′ UTR motifs that mediates the negative post-transcriptional regulation of RNA ([@ref-17]). K-box motif was not present in the wild type UTR sequence of *PICALM* gene and the addition of the motif may affect transcript turnover and translational efficiency.

In the wild type 3′ UTR sequence of *SYNJ1* gene, a total of 20 motifs were identified from UTRScan. Three 3′ UTR variants, including [rs777138831](http://www.ncbi.nlm.nih.gov/snp/?term=rs777138831), [rs147590143](http://www.ncbi.nlm.nih.gov/snp/?term=rs147590143) and [rs111516740](http://www.ncbi.nlm.nih.gov/snp/?term=rs111516740), caused an addition of upstream open reading frame (uORF) while another four variants, including [rs767649429](http://www.ncbi.nlm.nih.gov/snp/?term=rs767649429), [rs143739621](http://www.ncbi.nlm.nih.gov/snp/?term=rs143739621), [rs761852713](http://www.ncbi.nlm.nih.gov/snp/?term=rs761852713) and [rs79652470](http://www.ncbi.nlm.nih.gov/snp/?term=rs79652470), resulted in a deletion of uORF in 3′ UTR. Variant [rs780084162](http://www.ncbi.nlm.nih.gov/snp/?term=rs780084162) caused an additional motif named UNR-binding site (UNR-bs). UNR is one of the RNA-binding proteins that acts as a regulator in the initiation of internal ribosomal entry site (IRES)-mediated translation and cap-dependent translation ([@ref-40]). Therefore, variant [rs780084162](http://www.ncbi.nlm.nih.gov/snp/?term=rs780084162) may affect the expression of *SYNJ1* gene and the actual biological effect of the additional UNR-bs needs to be further experimentally validated.

For *SH3KBP1* gene, there were a total of 21 motifs identified in the wild type 3′ and 5′ UTR sequences. Variant [rs192424738](http://www.ncbi.nlm.nih.gov/snp/?term=rs192424738) caused an addition of uORF; variant [rs755895016](http://www.ncbi.nlm.nih.gov/snp/?term=rs755895016) caused a deletion of uORF in the 3′ UTR sequence. Variant [rs778448080](http://www.ncbi.nlm.nih.gov/snp/?term=rs778448080) resulted in a deletion of GY-box at position 2064--2070 of the 3′ UTR sequence. Like K-box and Brd-box, GY-box is one of the 3′ UTR motifs that mediates the negative post-translational regulation of RNA ([@ref-25]). Therefore, deletion of the GY-box caused by variant [rs778448080](http://www.ncbi.nlm.nih.gov/snp/?term=rs778448080) may affect the translation efficiency of *SH3KBP1* gene.

[Table 1](#table-1){ref-type="table"} lists the variants that change the number of motif matched in UTRSite, as compared with their wild type UTR sequences (see [Table S3](#supp-8){ref-type="supplementary-material"} for complete prediction analysis results). Both 3′and 5′UTRs are enriched with *cis*-acting regulatory elements, and both UTRs are important for the transcriptional and translational regulation. In this study, a total of 12 UTR variants were predicted to cause an addition or a deletion of regulatory elements in the UTR sequences. Further analysis on the impacts of these regulatory elements, including the effect of the miRNA binding to the UTR sequence is outside the scope of this study. However, it should be characterized in the future.

10.7717/peerj.7667/table-1

###### Variants with altered functional pattern(s) of the UTRs of *PICALM*, SYNJ1 and SH3KBP1 genes.

![](peerj-07-7667-g004)

  **Variants ID**                                                    **Ref/Alt**   **Minor allele frequency**   **Number of motif**   **Remarks**   
  ------------------------------------------------------------------ ------------- ---------------------------- --------------------- ------------- --------------------------------------------------------------------------------------------------------
  ***PICALM***                                                                                                                                      
  Wild type                                                                                                     10                    1             
  [rs796143140](http://www.ncbi.nlm.nih.gov/snp/?term=rs796143140)   T/C           NA                           11                    1             Addition of K-box at position 212-219
  ***SYNJ1***                                                                                                                                       
  Wild type                                                                                                     20                    --            
  [rs777138831](http://www.ncbi.nlm.nih.gov/snp/?term=rs777138831)   G/C           NA                           21                    --            Addition of uORF at position 1915-1995
  [rs147590143](http://www.ncbi.nlm.nih.gov/snp/?term=rs147590143)   G/T           NA                           21                    --            Addition of uORF at position 1915-1995
  [rs780084162](http://www.ncbi.nlm.nih.gov/snp/?term=rs780084162)   G/T           NA                           21                    --            Addition of UNR-bs at position 1037-1047
  [rs767649429](http://www.ncbi.nlm.nih.gov/snp/?term=rs767649429)   -/AA          NA                           19                    --            Deletion of uORF at position 942-1037
  [rs143739621](http://www.ncbi.nlm.nih.gov/snp/?term=rs143739621)   G/A           0.00002/2                    19                    --            Deletion of uORF at position 942-1037
  [rs111516740](http://www.ncbi.nlm.nih.gov/snp/?term=rs111516740)   G/A           0.0004/54                    21                    --            Addition of uORF at position 887-979
  [rs761852713](http://www.ncbi.nlm.nih.gov/snp/?term=rs761852713)   -/G           0.0001/7                     17                    --            Deletion of uORFs at position 372-437, 464-535 and 644-751
  [rs79652470](http://www.ncbi.nlm.nih.gov/snp/?term=rs79652470)     C/T           0.0001/13                    17                    --            Deletion of uORFs at position 182-289, 372-437, 464-535, 644-751, addition of uORF at position 205-810
  ***SH3KBP1***                                                                                                                                     
  Wild type                                                                                                     19                    2             
  [rs778448080](http://www.ncbi.nlm.nih.gov/snp/?term=rs778448080)   G/T           NA                           18                    2             Deletion of GY-box at position 2064-2070
  [rs192424738](http://www.ncbi.nlm.nih.gov/snp/?term=rs192424738)   C/T           NA                           20                    2             Addition of uORF at position 1380-1469
  [rs755895016](http://www.ncbi.nlm.nih.gov/snp/?term=rs755895016)   A/-           NA                           18                    2             Deletion of uORF at position 1299-1370

Prediction analysis of splice site variants
-------------------------------------------

The prediction analysis of splice site variants was done using MaxEntScan, which is integrated in VEP. Submission to MaxEntScan requires only the variant IDs. The consensus score and score difference between wild type and mutant sequences were obtained after the submission. The consensus score for each variant was calculated based on different protein-coding transcripts and the same variant may have different consensus scores on different transcripts. This allowed users to study the impact of the splicing variant on different transcripts. [Table 2](#table-2){ref-type="table"} shows the variants with score difference exceeding the defined threshold. Columns "MaxEntScan Ref" and "MaxEntScan Alt" indicate the wild type and mutant consensus scores, respectively. "Score difference" shows the differences between the wild type and mutant consensus scores (as percentages) to predict the variant effects in causing exon extension, intron retention or splice site creation. [Table S4](#supp-8){ref-type="supplementary-material"} comprises the complete prediction analysis results for all the splice site variants.

10.7717/peerj.7667/table-2

###### List of variants predicted to break or create splice site of *PICALM*, *SYNJ1* and *SH3KBP1* genes.

![](peerj-07-7667-g005)

  **Variants ID**                                                    **Ref/Alt**   **Minor allele frequency**   **Exon**   **Intron**   **MaxEntScanRef**   **MaxEntScanAlt**   **Score difference (%)**
  ------------------------------------------------------------------ ------------- ---------------------------- ---------- ------------ ------------------- ------------------- --------------------------
  ***PICALM***                                                                                                                                                                  
  [rs371001564](http://www.ncbi.nlm.nih.gov/snp/?term=rs371001564)   G/A           0.00002/2                    15/20                   9.065917            0.623344            −93.12
  [rs781144984](http://www.ncbi.nlm.nih.gov/snp/?term=rs781144984)   T/C           0.000008/1                   16/20                   7.971843            2.847240            −64.28
  [rs768239913](http://www.ncbi.nlm.nih.gov/snp/?term=rs768239913)   A/G           0.00007/8                    18/20                   8.542122            2.867856            −66.43
  ***SYNJ1***                                                                                                                                                                   
  [rs779813770](http://www.ncbi.nlm.nih.gov/snp/?term=rs779813770)   C/A           0.00009/1                               1/32         8.703310            0.199354            −97.71
  [rs376825246](http://www.ncbi.nlm.nih.gov/snp/?term=rs376825246)   T/C           0.000008/1                              11/32        7.844178            3.885060            −50.47
  [rs756697570](http://www.ncbi.nlm.nih.gov/snp/?term=rs756697570)   C/T           0.00005/6                    12/33                   7.638176            5.268185            −31.03
  [rs748110438](http://www.ncbi.nlm.nih.gov/snp/?term=rs748110438)   G/T           0.00003/3                               13/32        8.681559            0.239421            −97.24
  [rs367718431](http://www.ncbi.nlm.nih.gov/snp/?term=rs367718431)   T/G           0.000009/1                              13/32        8.681559            5.646822            −34.96
  [rs367718431](http://www.ncbi.nlm.nih.gov/snp/?term=rs367718431)   T/C           0.000009/1                              13/32        8.681559            4.215421            −51.44
  [rs758644105](http://www.ncbi.nlm.nih.gov/snp/?term=rs758644105)   G/T           0.000008/1                              16/32        8.941208            0.759180            −91.51
  [rs746368700](http://www.ncbi.nlm.nih.gov/snp/?term=rs746368700)   A/T           0.000009/1                   17/33                   9.256318            4.683645            −49.40
  [rs538934316](http://www.ncbi.nlm.nih.gov/snp/?term=rs538934316)   C/T           0.00003/4                               19/32        5.263433            −3.346463           −163.58
  [rs755765674](http://www.ncbi.nlm.nih.gov/snp/?term=rs755765674)   A/C           0.00002/2                    23/33                   6.505994            3.822270            −41.25
  [rs533064963](http://www.ncbi.nlm.nih.gov/snp/?term=rs533064963)   T/A           0.00002/3                               25/32        2.515213            3.906733            +55.32
  [rs61752550](http://www.ncbi.nlm.nih.gov/snp/?term=rs61752550)     G/A           0.0001/11                    29/33                   9.393973            3.084793            −67.16
  [rs373831795](http://www.ncbi.nlm.nih.gov/snp/?term=rs373831795)   T/A           NA                                      31/32        10.077445           1.573490            −84.39
  ***SH3KBP1***                                                                                                                                                                 
  [rs777396528](http://www.ncbi.nlm.nih.gov/snp/?term=rs777396528)   T/C           0.00001/1                               8/17         8.138004            4.452207            −45.29
  [rs61761898](http://www.ncbi.nlm.nih.gov/snp/?term=rs61761898)     G/C           0.0035/303                   15/18                   9.095315            5.850377            −35.68

A total of 18 variants were predicted to either disrupt or create splice sites, including 3, 13 and 2 variants from *PICALM*, *SYNJ1* and *SH3KBP1* genes, respectively. Among these variants, 17 were predicted to disrupt the splice site, in which splicing was omitted or disrupted, resulting in exon extension or intron retention. Variant [rs533064963](http://www.ncbi.nlm.nih.gov/snp/?term=rs533064963) in *SYNJ1* gene was the only variant predicted to create a new splice site in the intron.

Genetic variations are known to affect alternative splicing. For example, some risk alleles in genes including *CLU*, *PICALM* and *PTK2B* exert their biological impacts through alternative splicing in the pathogenesis of AD ([@ref-36]). The 18 splice site variants that were predicted to cause alternative splicing in this study should be further investigated for their structural and functional impacts on the proteins.

Prediction analysis of sSNPs
----------------------------

Out of the 399 sSNPs we studied, eight sSNPs were predicted as deleterious sSNPs in PredictSNP2, including five from *PICALM* gene and three from *SYNJ1* gene. [Table 3](#table-3){ref-type="table"} shows the eight deleterious sSNPs. [Tables S5](#supp-9){ref-type="supplementary-material"}--[S7](#supp-11){ref-type="supplementary-material"} describe the complete prediction results of sSNPs in *PICALM*, *SYNJ1* and *SH3KBP1* genes, respectively.

10.7717/peerj.7667/table-3

###### Deleterious sSNPs of *PICALM* and *SYNJ1* genes predicted by PredictSNP2.

![](peerj-07-7667-g006)

  **Variants ID**                                                    **Ref/Alt**   **Minor allele frequency**   **CADD**   **DANN**   **FATHMM**   **FunSeq2**   **GWAVA**   **PredictSNP2**
  ------------------------------------------------------------------ ------------- ---------------------------- ---------- ---------- ------------ ------------- ----------- -----------------
  ***PICALM***                                                                                                                                                               
  [rs779752380](http://www.ncbi.nlm.nih.gov/snp/?term=rs779752380)   C/G           0.000010/1                   15.54      0.947688   0.91404      4             0.37        0.549842
  [rs777199260](http://www.ncbi.nlm.nih.gov/snp/?term=rs777199260)   A/G           0.000008/1                   8.879      0.869109   0.93421      4             0.42        0.091749
  [rs775830584](http://www.ncbi.nlm.nih.gov/snp/?term=rs775830584)   T/C           NA                           13.32      0.963935   0.21828      3             0.32        0.111345
  [rs759002840](http://www.ncbi.nlm.nih.gov/snp/?term=rs759002840)   G/A           0.0002/20                    17.47      0.964966   0.79634      0             0.34        0.459234
  [rs367839126](http://www.ncbi.nlm.nih.gov/snp/?term=rs367839126)   G/A           0.00003/3                    19.81      0.959689   0.889        0             0.41        0.485786
  ***SYNJ1***                                                                                                                                                                
  [rs768565296](http://www.ncbi.nlm.nih.gov/snp/?term=rs768565296)   C/T           0.000010/1                   17.88      0.91747    0.91944      0             0.58        0.473949
  [rs869206401](http://www.ncbi.nlm.nih.gov/snp/?term=rs869206401)   G/A           NA                           22.4       0.934833   0.75779      0             0.51        0.028194
  [rs772641102](http://www.ncbi.nlm.nih.gov/snp/?term=rs772641102)   G/A           NA                           21.4       0.942502   0.36483      0             0.41        0.019858

Among the 99 sSNPs in *PICALM* gene, five were predicted to have deleterious effects. Four out of those five, including [rs779752380](http://www.ncbi.nlm.nih.gov/snp/?term=rs779752380), [rs777199260](http://www.ncbi.nlm.nih.gov/snp/?term=rs777199260), [rs775830584](http://www.ncbi.nlm.nih.gov/snp/?term=rs775830584) and [rs759002840](http://www.ncbi.nlm.nih.gov/snp/?term=rs759002840), are located on the PICALM ANTH domain. Among the three deleterious sSNPs in *SYNJ1* gene, only [rs768565296](http://www.ncbi.nlm.nih.gov/snp/?term=rs768565296) is located on the 5-phosphatase domain of the protein. For *SH3KBP1* gene, all the 112 sSNPs were predicted to have neutral effects on the gene.

sSNPs affect protein expression and conformation through the regulation of RNA splicing, mRNA stability, translation dynamics, translation rate and co-translational folding of the protein ([@ref-41]). The actual biological impacts of the eight deleterious sSNPs predicted in this study should be validated in the future.

Prediction analysis of nsSNPs
-----------------------------

All 759 nsSNPs in the three genes were analyzed by five prediction packages. The Ensembl genome database contains prediction results from SIFT and PolyPhen-2, in which a total of 106 nsSNPs were predicted as "damaging" in SIFT and "probably damaging" in PolyPhen-2. Together with the prediction results from Mutation Assessor, I-Mutant2.0 and SNPs&GO, a total of 18 nsSNPs exceeded the cutoff points of all five packages and were identified as deleterious nsSNPs. The prediction results of the deleterious nsSNPs are summarized in [Table 4](#table-4){ref-type="table"} while the complete prediction results of nsSNPs using five prediction packages are shown in [Table S8](#supp-12){ref-type="supplementary-material"}. All the deleterious nsSNPs were predicted with high SIFT score and most of them have a PSIC score larger than 0.95 in PolyPhen-2. Prediction results from SIFT and PolyPhen-2 showed that all deleterious nsSNPs were highly conserved in the proteins ([Table 4](#table-4){ref-type="table"}).
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###### Prediction of *PICALM*, *SYNJ1* and *SH3KBP1* deleterious nsSNPs.

![](peerj-07-7667-g007)

  **Variant ID**                                                     **AA Subs**   **Minor allele frequency**   **SIFT score**   **PolyPhen PSIC score**   **Mutation assessor**   **I-Mutant DDG**   **SNPs&GO**
  ------------------------------------------------------------------ ------------- ---------------------------- ---------------- ------------------------- ----------------------- ------------------ -------------
  ***PICALM***                                                                                                                                                                                        
  [rs750147583](http://www.ncbi.nlm.nih.gov/snp/?term=rs750147583)   L106S         NA                           0                0.999                     Medium                  −1.93              0.644
  [rs780443419](http://www.ncbi.nlm.nih.gov/snp/?term=rs780443419)   F109S         0.00001                      0                0.994                     Medium                  −2.81              0.794
  [rs145115354](http://www.ncbi.nlm.nih.gov/snp/?term=rs145115354)   D144N         0.000008                     0                1                         Medium                  −1.57              0.784
  [rs765338634](http://www.ncbi.nlm.nih.gov/snp/?term=rs765338634)   L179P         0.00001                      0                0.989                     Medium                  −2.29              0.692
  ***SYNJ1***                                                                                                                                                                                         
  [rs781675993](http://www.ncbi.nlm.nih.gov/snp/?term=rs781675993)   N200K         0.000008                     0                0.99                      High                    −1.34              0.735
  [rs398122403](http://www.ncbi.nlm.nih.gov/snp/?term=rs398122403)   R258Q         0.00002                      0                0.978                     High                    −1.23              0.841
  [rs762909719](http://www.ncbi.nlm.nih.gov/snp/?term=rs762909719)   R289Q         0.000009                     0                1                         High                    −1.77              0.723
  [rs771755243](http://www.ncbi.nlm.nih.gov/snp/?term=rs771755243)   V338A         0.000008                     0                0.928                     Medium                  −1.16              0.598
  [rs768897710](http://www.ncbi.nlm.nih.gov/snp/?term=rs768897710)   Q414R         0.000008                     0                0.999                     High                    −1.14              0.751
  [rs779479360](http://www.ncbi.nlm.nih.gov/snp/?term=rs779479360)   G437D         0.00002                      0                0.939                     Medium                  −1.42              0.736
  [rs775515863](http://www.ncbi.nlm.nih.gov/snp/?term=rs775515863)   G487R         0.000008                     0                0.988                     Medium                  −1.81              0.79
  [rs752563697](http://www.ncbi.nlm.nih.gov/snp/?term=rs752563697)   G494D         0.000008                     0                0.943                     High                    −1.74              0.632
  [rs771070426](http://www.ncbi.nlm.nih.gov/snp/?term=rs771070426)   I515T         0.000008                     0                0.969                     Medium                  −3.5               0.653
  [rs756845805](http://www.ncbi.nlm.nih.gov/snp/?term=rs756845805)   G627S         0.000008                     0                0.999                     Medium                  −1.6               0.751
  [rs751110096](http://www.ncbi.nlm.nih.gov/snp/?term=rs751110096)   C723G         0.000008                     0                0.996                     Medium                  −2.59              0.826
  [rs147929290](http://www.ncbi.nlm.nih.gov/snp/?term=rs147929290)   I746T         0.000008                     0.03             0.951                     Medium                  −2.42              0.633
  [rs745418083](http://www.ncbi.nlm.nih.gov/snp/?term=rs745418083)   L776P         0.000008                     0                0.981                     Medium                  −2.32              0.861
  ***SH3KBP1***                                                                                                                                                                                       
  [rs770229859](http://www.ncbi.nlm.nih.gov/snp/?term=rs770229859)   R648Q         NA                           0                0.951                     Medium                  −1.07              0.658

There were four deleterious nsSNPs in *PICALM* gene predicted in this study. All of them are located in amino acids 106 to 179 of the PICALM sequence. Positions 106 to 179 are located on the PICALM protein ANTH domain (23 to 283 aa) and ENTH domain (14 to 145 aa), and these two domains were reported to be functionally redundant ([@ref-26]; [@ref-28]). The ANTH domain of the protein is important in the binding to phosphatidylinositol 4,5-bisphosphate (PIP2). The binding of PICALM to PIP2 is important for the formation of clathrin-coated pit, which is one of the key functions of PICALM in CME ([@ref-22]). These deleterious nsSNPs were predicted to cause conformation change and affect PICALM protein function. [Fig. 1](#fig-1){ref-type="fig"} shows the sticks representation of the protein structural changes caused by the deleterious nsSNPs in *PICALM* gene. In [Fig. 1](#fig-1){ref-type="fig"}, the variant residues are colored yellow while red dashed lines indicate the hydrogen bonds between the residues. Variants [rs780443419](http://www.ncbi.nlm.nih.gov/snp/?term=rs780443419) (F109S) and [rs765338634](http://www.ncbi.nlm.nih.gov/snp/?term=rs765338634) (L179P) resulted in an addition or a deletion of hydrogen bond formation between the mutant and neighboring amino acids. Therefore, the substitution of these protein residues could significantly affect the ANTH domain function as well as the overall PICALM protein structure.

![Structural comparison between the wild type and mutant amino acids of PICALM protein in sticks representation.\
No addition or deletion of hydrogen bonds between the mutant residues and the surrounding residues were identified in variants (B) [rs750147583](http://www.ncbi.nlm.nih.gov/snp/?term=rs750147583) (L106S) and (F) [rs145115354](http://www.ncbi.nlm.nih.gov/snp/?term=rs145115354) (D144N), as compared to their wild type structures as shown in (A) and (E), respectively. (D) Variant [rs780443419](http://www.ncbi.nlm.nih.gov/snp/?term=rs780443419) (F109S) resulted in addition of hydrogen bond with residues L106, as compared to its wild type structure as shown in (C). (H) Variant [rs765338634](http://www.ncbi.nlm.nih.gov/snp/?term=rs765338634) (L179P) resulted in deletion of hydrogen bonds between residues M175 and D176, as compared to its wild type structure as shown in (G).](peerj-07-7667-g001){#fig-1}

For *SYNJ1* gene, 13 nsSNPs were predicted as deleterious. Six of them including [rs781675993](http://www.ncbi.nlm.nih.gov/snp/?term=rs781675993), [rs398122403](http://www.ncbi.nlm.nih.gov/snp/?term=rs398122403), [rs762909719](http://www.ncbi.nlm.nih.gov/snp/?term=rs762909719), [rs771755243](http://www.ncbi.nlm.nih.gov/snp/?term=rs771755243), [rs768897710](http://www.ncbi.nlm.nih.gov/snp/?term=rs768897710) and [rs779479360](http://www.ncbi.nlm.nih.gov/snp/?term=rs779479360) are located on the Sac domain while another four including [rs756845805](http://www.ncbi.nlm.nih.gov/snp/?term=rs756845805), [rs751110096](http://www.ncbi.nlm.nih.gov/snp/?term=rs751110096), [rs147929290](http://www.ncbi.nlm.nih.gov/snp/?term=rs147929290) and [rs745418083](http://www.ncbi.nlm.nih.gov/snp/?term=rs745418083) are located on the 5-phosphatase domain. Both Sac domain and 5-phosphatase domain mediate the crucial SYNJ1 protein function of phosphate hydrolysis, and they were reported to function in a concerted way (see review in [@ref-21]). Besides that, a previous study has shown that both Sac and 5-phosphatase domains are important in the synaptic vesicle endocytosis and SYNJ1 D730A mutant completely eliminated the activity of 5-phosphastase domain ([@ref-27]). Although the actual impact of the predicted deleterious variants is yet to be determined, these variants may affect the domains function and influence the role of SYNJ1 in endocytosis as well.

![Evolutionary conservation of the deleterious nsSNPs of PICALM, SYNJ1, and SH3KBP1 proteins by ConSurf server.\
(A), (B) and (C) showed the ConSurf output for PICALM, SYNJ1, and SH3KBP1 protein sequences, respectively. The position of each deleterious variant is labeled with a black rectangle.](peerj-07-7667-g002){#fig-2}

Variant [rs770229859](http://www.ncbi.nlm.nih.gov/snp/?term=rs770229859) is the only predicted deleterious nsSNP in *SH3KBP1* gene. This variant changed residue arginine to glutamine at position 648, which is the C-terminal coiled-coil domain of the protein. The coiled-coil domain of SH3KBP1 was previously reported to be important in mediating the interaction between SH3KBP1 and phosphatidic acid ([@ref-54]). Moreover, deletion of the coiled-coil domain directly affected the binding of SH3KBP1 to c-Cbl ubiquitin ligases, in which the interaction is essential for the initiation of CME regulated by SH3KBP1 ([@ref-54]). Interestingly, another study has found that alanine mutation of four basic amino acids (K645, K646, R648 and R650) on the coiled-coil domain can completely disrupt the interaction of SH3KBP1 with phosphatidic acid and c-Cbl ([@ref-56]). Since the deleterious nsSNP [rs770229859](http://www.ncbi.nlm.nih.gov/snp/?term=rs770229859) resulted in amino acid substitution at position 648 of SH3KBP1, this variant is predicted to have a high likelihood of influencing the functions of the coiled-coil domain.

The structural and functional importance of the 18 deleterious nsSNPs were further analyzed using ConSurf analysis tools. Evolutionary conservation analysis determines the level of conservation of each protein residue and predicts the potential structural and functional importance of these deleterious variants to the protein. [Figure 2](#fig-2){ref-type="fig"} shows that 17 out of 18 (94%) deleterious nsSNPs were analyzed to be "conserved", with 12 of them (70%) "highly conserved" (score "9") through homologous sequence alignment. Only one deleterious nsSNP, [rs745418083](http://www.ncbi.nlm.nih.gov/snp/?term=rs745418083) (L776S) in *SYNJ1* gene, was estimated to be "intermediate" in terms of evolutionary conservation. Besides that, 11 of the 18 (61%) deleterious variants were predicted as structural residues and the rest (39%) were functional residues. [Figures S2](#supp-2){ref-type="supplementary-material"}--[S4](#supp-4){ref-type="supplementary-material"} shows the conservation scores of full length proteins of PICALM, SYNJ1 and SH3KBP1, respectively.

Besides the prediction analysis of the functional and structural importance of the deleterious nsSNPs and their level of conservation on the proteins, the changes of physical and chemical properties between wild type and mutant amino acids were studied. [Table S9](#supp-13){ref-type="supplementary-material"} shows the hydropathy, polarity and charge differences between the wild type and mutant amino acids of the deleterious nsSNPs.

During protein synthesis, both covalent and non-covalent interactions are driven by the physical and chemical properties of the amino acids. The hydropathy, size and charge of the amino acids all play important roles in the protein synthesis ([@ref-6]). [Table S9](#supp-13){ref-type="supplementary-material"} shows that the hydropathy in eight deleterious nsSNPs has changed from hydrophobic to hydrophilic, and the polarity of four nsSNPs has changed from non-polar to polar. The substitution of amino acids may affect both covalent and non-covalent interactions among amino acids, subsequently influencing the stability and conformation of protein structure.

To study the role of nsSNPs in affecting the total free energy and the stability of protein structures, full lengths of both wild type and mutant protein structures were modelled with the use of SPARKS-X server ([@ref-52]), and the structures were refined by using ModRefiner ([@ref-51]). Energy minimization of the protein structures was performed by GROMOS96 force field using Swiss-PdbViewer. [Table 5](#table-5){ref-type="table"} shows the energy deviation and RMSD between wild type protein structures of PICALM, SYNJ1 and SH3KBP1, and the 18 mutant protein structures of deleterious nsSNPs. RMSD values were calculated to provide an insight into the deviation between the wild type and mutant protein structures. The RMSD values are proportional to the deviation between the wild type and mutant structures. The total free energy of wild type PICALM structure was −24,238.746 kJ/mol, and the total free energy of the four PICALM mutant structures was marginally decreased. The RMSD values also showed a minor deviation ranging from 1.13 to 1.45 Å. For SYNJ1 protein, the total free energy of the wild type structure was -19307.051 kJ/mol. The deviation of total free energy between SYNJ1 wild type and mutant protein structures is significant. Among the 13 SYNJ1 mutant structures, variant [rs398122403](http://www.ncbi.nlm.nih.gov/snp/?term=rs398122403) (R258Q) has the highest total free energy of 3,057.503 kJ/mol, and variant [rs775515863](http://www.ncbi.nlm.nih.gov/snp/?term=rs775515863) (G487R) has the lowest total free energy of −28,591.270 kJ/mol. Among all the *SYNJ1* variants, [rs781675993](http://www.ncbi.nlm.nih.gov/snp/?term=rs781675993) (N200K) has the highest RMSD value of 2.34 Å. [Figure 3](#fig-3){ref-type="fig"} shows the structural comparison of the wild type SYNJ1 structure (green) and [rs781675993](http://www.ncbi.nlm.nih.gov/snp/?term=rs781675993) mutant structure (blue). Superposition of the two structures shows the structural deviation caused by the variant. The only SH3KBP1 mutant structure caused by variant [rs770229859](http://www.ncbi.nlm.nih.gov/snp/?term=rs770229859) (R648Q) showed a decreased total free energy of −1,6167.838 kJ/mol, with a RMSD value of 1.88 Å.
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###### Total energy deviation and RMSD of deleterious nsSNPs of PICALM, SYNJ1 and SH3KBP1 proteins.
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  **Variant ID**                                                     **AA Subs.**   **Total energy (kJ/mol)**   **Energy difference**   **RMSD (Å)**
  ------------------------------------------------------------------ -------------- --------------------------- ----------------------- --------------
  **PICALM (wild type)**                                                            −24,238.746                                         
  [rs750147583](http://www.ncbi.nlm.nih.gov/snp/?term=rs750147583)   L106S          −24,759.834                 −521.088                1.26
  [rs780443419](http://www.ncbi.nlm.nih.gov/snp/?term=rs780443419)   F109S          −24,921.291                 −682.545                1.45
  [rs145115354](http://www.ncbi.nlm.nih.gov/snp/?term=rs145115354)   D144N          −24,494.619                 −255.873                1.45
  [rs765338634](http://www.ncbi.nlm.nih.gov/snp/?term=rs765338634)   L179P          −24,824.025                 −585.279                1.13
  **SYNJ1 (wild type)**                                                             −19,307.051                                         
  [rs781675993](http://www.ncbi.nlm.nih.gov/snp/?term=rs781675993)   N200K          −11,031.447                 +8,275.604              2.34
  [rs398122403](http://www.ncbi.nlm.nih.gov/snp/?term=rs398122403)   R258Q          3,057.503                   +22,364.554             2.15
  [rs762909719](http://www.ncbi.nlm.nih.gov/snp/?term=rs762909719)   R289Q          −21,897.707                 −2,590.656              2.02
  [rs771755243](http://www.ncbi.nlm.nih.gov/snp/?term=rs771755243)   V338A          −17,907.066                 +1,399.985              2.09
  [rs768897710](http://www.ncbi.nlm.nih.gov/snp/?term=rs768897710)   Q414R          −18,169.162                 +1,137.889              2.04
  [rs779479360](http://www.ncbi.nlm.nih.gov/snp/?term=rs779479360)   G437D          −19,518.217                 −211.166                2.08
  [rs775515863](http://www.ncbi.nlm.nih.gov/snp/?term=rs775515863)   G487R          −28,591.270                 −9,284.219              2.1
  [rs752563697](http://www.ncbi.nlm.nih.gov/snp/?term=rs752563697)   G494D          −6,042.169                  +13,264.882             2.24
  [rs771070426](http://www.ncbi.nlm.nih.gov/snp/?term=rs771070426)   I515T          −9,617.264                  +9,689.787              2.13
  [rs756845805](http://www.ncbi.nlm.nih.gov/snp/?term=rs756845805)   G627S          −25,429.416                 −6,122.365              2.13
  [rs751110096](http://www.ncbi.nlm.nih.gov/snp/?term=rs751110096)   C723G          −23,460.332                 −4,153.281              1.83
  [rs147929290](http://www.ncbi.nlm.nih.gov/snp/?term=rs147929290)   I746T          −20,893.076                 −1,586.025              2.25
  [rs745418083](http://www.ncbi.nlm.nih.gov/snp/?term=rs745418083)   L776P          −18,299.359                 +1,007.692              2.14
  **SH3KBP1 (wild type)**                                                           −15,365.350                                         
  [rs770229859](http://www.ncbi.nlm.nih.gov/snp/?term=rs770229859)   R648Q          −16,167.838                 −802.488                1.88

![Superposition of wild type SYNJ1 structure and variant [rs781675993](http://www.ncbi.nlm.nih.gov/snp/?term=rs781675993) (N200K) mutant structure.\
This figure shows the truncated protein structure of 100 residues around the mutant sites. Wild type SYNJ1 structure is green, and mutant SYNJ1 structure is blue. Wild type residue (N) at position 200 is red, and mutant residue (K) at position 200 is purple.](peerj-07-7667-g003){#fig-3}

Verification of nsSNP prediction principle
------------------------------------------

To demonstrate the reliability of nsSNP prediction, we predicted the functional consequences of other nsSNPs that have been previously studied in other benchwork experiments. Ten *PSEN1* pathogenic nsSNPs that have been validated experimentally to affect amyloid-beta (Aβ) level were retrieved from ALZFORUM (<https://www.alzforum.org/>). Besides that, another five *PSEN1* nsSNPs, including three non-pathogenic variants and two variants that have never been reported to be deleterious or disease-associated, were selected as negative controls. The prediction results of the total 15 nsSNPs in *PSEN1* gene are shown in [Table S10](#supp-10){ref-type="supplementary-material"}. The prediction results show that nine out of these ten pathogenic nsSNPs were predicted deleterious by all five prediction packages used in this paper. The only pathogenic nsSNP that was not predicted as deleterious variant, which is [rs63750231](http://www.ncbi.nlm.nih.gov/snp/?term=rs63750231) (E280A), has I-Mutant DDG and SNPs&GO score that is lower than the cutoff point. All these five negative controls of *PSEN1* nsSNPs were predicted to be non-deleterious to the protein.

Computational prediction of the biological consequences of variants was previously reported to yield a high false positive (FP) and low false negative (FN) rate, suggesting that computational prediction tends to overestimate the deleterious effects of variants ([@ref-31]). To reduce the FP rate, our study implemented meta-prediction method to perform functional prediction of nsSNPs. Despite one FN prediction result ([rs63750231](http://www.ncbi.nlm.nih.gov/snp/?term=rs63750231)) was reported, the overall prediction results of the *PSEN1* pathogenic and non-pathogenic nsSNPs indicate that the prediction approaches which were used, reliably predicted the functional consequences of nsSNPs.

NGS data of AD studies
----------------------

To check if any of the 56 deleterious variants were identified in the next generation sequencing (NGS) studies of AD, genotype calling data (variant calling format (.VCF) files) were retrieved from three studies including Alzheimer's Disease Sequencing Project (ADSP), Alzheimer's Disease Neuroimaging Initiative (ADNI) and Mount Sinai Brain Bank (MSBB) studies. ADSP aims to identify genetic variants that increase the risk for or protect against AD. The study consists of two parts, including a whole genome sequencing (WGS) of 584 samples family-based study and a whole exome sequencing (WES) of 10,061 samples case-control study ([@ref-4]). Genotype calling data of both WGS and WES were retrieved from the study. For ADNI, the study is primarily designed to discover novel biomarkers from a total of 800 individuals for the early detection of AD. The 800 individuals consist of 200 elderly controls, 400 mild cognitive impairment (MCI) and 200 AD patients. WGS of the 800 individuals was performed in the following add-on study and the genotype calling data is publicly available ([@ref-49]). For MSBB study, it aims to discover novel molecular mechanism of AD pathogenesis from genomic, transcriptomic and proteomic data consisting of 364 AD case-control human brains ([@ref-48]). The raw and processed data of MSBB study are available through the Synapse software platform (<https://www.synapse.org/#!Synapse:syn3159438>) and the .VCF file of WES of the study was retrieved.

Among the 56 deleterious variants predicted in this study, seven variants were also identified in ADSP, ADNI or MSBB studies. [Table S11](#supp-15){ref-type="supplementary-material"} shows the deleterious variants that were identified in the NGS studies of AD. Identification of these deleterious variants in these NGS studies further suggests their potential association with AD. In these studies, the genotype data was mapped on the reference genome GRCh37 while the variant data retrieved from Ensembl genome database was mapped on GRCh38. Therefore, the variant positions in both GRCh37 and GRCh38 are provided in [Table S11](#supp-15){ref-type="supplementary-material"}.

Discussion
==========

In this study, a total of 56 SNPs in *PICALM*, *SYNJ1* and *SH3KBP1* genes were predicted as deleterious variants for the genes and their gene products. These deleterious variants included 12 UTR variants, 18 splice site variants, 8 sSNPs and 18 nsSNPs. These 12 deleterious UTR variants were predicted to cause an addition or a deletion of *cis*-acting elements in UTR sequences, which may affect the post-transcriptional regulation of the genes. These 18 deleterious splice site variants were predicted to disrupt gene splicing, which can produce truncated or extended forms of the proteins. Meta-analysis by PredictSNP2 has predicted a total of 8 deleterious sSNPs in *PICALM* and *SYNJ1* genes. These deleterious UTR variants, splice site variants and sSNPs were expected to affect the regulation of gene expression, as well as the stability of the mRNAs. For the 18 deleterious nsSNPs, most of them are located on the functional domains of the proteins. These domains mediate the main protein functions in the regulation of clathrin-mediated endocytosis (CME). ANTH domain on PICALM regulates the formation of clathrin-coated pit while coiled-coil domain on SH3KBP1 has an important role in the initiation of CME ([@ref-22]; [@ref-54]). Specifically, both of the domains are involved in the early stage of CME. For SYNJ1, the hydrolysis of PIP~2~ by Sac domain and 5-phosphatase domain may be involved in the disassembly of clathrin-coated vesicles ([@ref-21]), which is in the late stage of CME. Therefore, identification of deleterious nsSNPs on these functional domains may not only help to elucidate the functional impacts of these variants to the proteins, but also may gain insight into the biological roles of these domains in CME. Moreover, three endocytosis genes in this study have been linked to the pathogenesis of AD. Hence, the prediction analysis of the deleterious variants may be relevant for the gene-disease association study.

To date, GWAS and other genetic studies have successfully identified more than 20 risk genes associated with AD, but the molecular mechanisms of these genes remain to be determined. To understand the molecular basis of these AD-associated genes in the disease, one of the approaches is to identify functional SNPs from a vast number of neutral SNPs in the gene of interest. However, it was estimated that SNP occurs in every 100 to 300 bases and there are up to ten million SNPs in the entire human genome ([@ref-23]). The massive number of SNPs in the entire human genome makes it impractical to perform laboratory experiments to determine the functional consequences of all the SNPs, even for a single gene. For that reason, computational methods become an alternative and important way to prioritize the SNPs that are possibly structurally or functionally significant for the genes of interest. Computational methods such as prediction and modelling tools allow researchers to identify functionally significant SNPs from neutral SNPs. The prediction accuracy is expected to be improved when results from multiple algorithms are combined to perform meta-prediction. Besides that, computational methods are able to provide high throughput prediction results at lower cost and faster time, as compared with laboratory experiments. Although study by [@ref-31] has pointed out the low specificity of computational prediction, the discrepancy between the prediction and experimental results of the variants impacts can be further improved by providing a better data quality and input alignment design during computational prediction ([@ref-16]). In conclusion, computational methods is an essential part to provide initial assessment and prioritize the SNPs that are most likely to be functional, which can largely improve research efficiency.

Although computational methods can significantly contribute to the task of identifying functional SNPs, a limited number of studies had performed function prediction analysis of the variants located in the disease-associated genes. Moreover, most of the function prediction studies of variants only focus on annotating the functional consequences and disease-relatedness of nsSNP since it was conventionally thought to have a higher impact on the phenotype rather than the other types of variations. However, nsSNPs, sSNPs and 5′UTR variants have been reported to share similar likelihoods of association in Mendelian diseases ([@ref-11]). Other than these three types of variants, more than 18,000 of all variants reported in the Human Gene Mutation Database (HGMD) are splicing variants, which is about 9% of the total number of variants in the database ([@ref-43]). In the pathogenesis of complex diseases, the roles of genetic factors are much more complicated than those in Mendelian diseases. Genetic variants in non-coding regions may play a more prominent role than in coding regions in complex diseases since most of the disease-associated variants identified in GWAS are located in non-coding regions ([@ref-53]). Identifying pathogenic variants in both coding and non-coding regions of genes associated with complex diseases can help to explain the genetic factors and networks of the diseases. Therefore, this study does not target nsSNPs exclusively because it may overlook other functionally significant variants that are associated with AD.

To our knowledge, 55 out of the 56 deleterious variants predicted in this study were reported for the first time to be functionally or structurally significant for *PICALM*, *SYNJ1* and *SH3KBP1* genes, and their gene products. Only one deleterious variant, which is [rs398122403](http://www.ncbi.nlm.nih.gov/snp/?term=rs398122403) (R258Q) in *SYNJ1* gene, was previously reported to be associated with Parkinson's disease (PD) ([@ref-24]). Variant [rs398122403](http://www.ncbi.nlm.nih.gov/snp/?term=rs398122403) was found to disrupt the phosphatase activity of Sac domain on SYNJ1 protein, leading to an impaired synaptic function of SYNJ1 and causing an accumulation of endocytic proteins in the brains of mutant mice, developing neurological symptoms similar to PD patients ([@ref-8]). Although AD and PD have different clinical and pathological symptoms, many studies suggested that they share some common molecular mechanisms, such as oxidative stress and mitochondrial dysfunction (see review in [@ref-44]). However, in the case of SYNJ1, several studies suggested that the downregulation of SYNJ1 may alleviate the pathogenesis of AD ([@ref-29]; [@ref-58]). Intriguingly, the biological effects of the SYNJ1 in AD don't seem to be in line with budding yeast and *C. elegans* orthologues ([@ref-46]). Since the validated PD-associated variant [rs398122403](http://www.ncbi.nlm.nih.gov/snp/?term=rs398122403) was also predicted as deleterious variant in this study, and the mutant protein structure of this variant has the highest total free energy among all the deleterious variants, the prediction results of this study may serve as a good target for further investigation. Nevertheless, it is not known if the variant [rs398122403](http://www.ncbi.nlm.nih.gov/snp/?term=rs398122403) is also associated with AD. SYNJ1 is one of very few proteins associated with both AD and PD. Therefore, the *SYNJ1* variants predicted in this study may be useful to discover the biological roles of SYNJ1 on the molecular mechanisms in AD and PD.

Previously, several AD-associated common variants have been identified from GWAS. For example, variants [rs3851179](http://www.ncbi.nlm.nih.gov/snp/?term=rs3851179), [rs541458](http://www.ncbi.nlm.nih.gov/snp/?term=rs541458) and [rs561655](http://www.ncbi.nlm.nih.gov/snp/?term=rs561655) are associated with AD. These three variants were not identified in this study since they are intergenic variants which are located upstream of *PICALM* gene. On the other hand, the minor allele frequency (MAF) of these three SNPs are over 0.3, which is much higher as compared to the deleterious variants predicted in this study. Previous studies have reported that most of the AD-associated common variants have a smaller effect size on the disease risk as compared to rare variants (see review in [@ref-34]). Therefore, the current research direction is focused on identification of rare variants with a larger effect size that are located in different genes ([@ref-35]). The MAF of the 56 deleterious variants predicted in this study are provided in [Tables 1](#table-1){ref-type="table"}--[4](#table-4){ref-type="table"}. The MAF data was obtained from the Exome Aggregation Consortium (ExAC) in aggregated populations. All the deleterious variants are very rare variants (average MAF \< 0.00002). According to the "common disease common variant" (CDCV) hypothesis, the risk of getting a common disease would be relatively high along with the appearance of disease-predisposing alleles. Assuming that the common alleles are the actual cause of common diseases, many causative alleles would have been identified through GWAS. However, the current data do not seem to support this hypothesis since only a very limited number of variants have been successfully linked to the pathogenesis of certain diseases. Moreover, common variants identified from GWAS are insufficient to explain the missing heritability of complex phenotypes and diseases (see review in [@ref-7]). On the other hand, the rare variants absent in GWAS have been suggested to be an important factor in common disease susceptibility in the common disease rare variant (CDRV) hypothesis ([@ref-3]). Despite different strategies used in the identification of disease-associated variants in both hypotheses, they can work together to identify the common variants along with the genomic region and locus through GWAS, followed by conducting the functional analysis of the rare variants. Currently, no AD-associated rare variant in *PICALM*, *SYNJ1* and *SH3KBP1* genes has been reported by other studies so far. It is plausible that the sample size of GWAS might not be sufficient to identify disease-associated rare variants. Hence, our prediction analysis may be useful to identify functional variants which could be absent in GWAS due to their rare MAF.

Conclusion
==========

In our study, a total of 56 rare variants in *PICALM*, *SYNJ1* and *SH3KBP1* genes were predicted as deleterious variants. These deleterious variants were predicted to affect the regulation of gene expressions and protein functions. These genes have cellular functions involved in clathrin-mediated endocytosis (CME) and deleterious variants in these genes were expected to affect the functions of these proteins in endocytosis. Moreover, these genes were previously reported as AD-associated and they are implicated in the pathogenesis of AD. The deleterious variants in these genes may affect AD pathogenesis through the disruption of the gene expressions and protein functions. In addition, seven of the deleterious variants were also identified in three large NGS studies of AD, further suggesting their possible roles in AD pathogenesis. The actual roles of these deleterious variants in affecting protein functions in CME, as well as their implications in AD, are recommended to be validated by future laboratory experiments.
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